Search

Search Constraints

You searched for: Author/Creator Scott, Angela

Search Results

3. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. Issue 11 (November 2021)

4. Practice Guidelines for Canadian Neurophysiology Laboratories During the COVID-19 Pandemic. (19th January 2021)

5. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. Issue 1 (December 2016)

6. Response from Authors to the Letter to the Editor. (15th January 2021)

9. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Issue 3 (March 2023)